nach oben

Current Cardiology Reports

Erschienen in:

01.12.2013 | Stroke (C Sila, Section Editor)

Small Vessel Disease and Memory Loss: What the Clinician Needs to Know to Preserve Patients’ Brain Health

verfasst von: Christian Schenk, Timothy Wuerz, Alan J. Lerner

Erschienen in: Current Cardiology Reports | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Abstract

Small vessel disease (SVD) in the brain manifests in the periventricular and deep white matter and radiographically is described as “leukoaraiosis”. It is increasingly recognized as a cause of morbidity from middle age onward and this clinical relevance has paralleled advances in the field of neuroradiology. Overall, SVD is a heterogenous group of vascular disorders that may be asymptomatic, or a harbinger of many conditions that jeopardize brain health. Management and prevention focuses on blood pressure control, lifestyle modification, and symptomatic treatment.

Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. The Lancet Neurology. 2002;1(7):426–36.

Fisher CM. Lacunar strokes and infarcts: A review. American Academy of Neurology. 1982;32(8):871–6.

Chen X, Wen W, Anstey KJ, Sachdev PS. Prevalence, incidence, and risk factors of lacunar infarcts in a community sample. Neurology. 2009;73(4):266–72.PubMed

Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011;70(6):871–80.PubMed

Mehndiratta P, Manjila S, Ostergard T, Eisele S, Cohen ML, Sila C, et al. Cerebral amyloid angiopathy–associated intracerebral hemorrhage: Pathology and management. Neurosurg Focus. 2012;32(4):E7.PubMed

Poels MMF, Steyerberg EW, Wieberdink RG, Hofman A, Koudstaal PJ, Ikram MA, et al. Assessment of cerebral small vessel disease predicts individual stroke risk. Journal of Neurology, Neurosurgery & Psychiatry. 2012;83(12):1174–9.

Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38.PubMedCentralPubMed

•• Medrano Martorell S, Cuadrado Blázquez M, García Figueredo D, González Ortiz S, Capellades Font J. Hyperintense punctiform images in the white matter: A diagnostic approach. Radiología (English Edition). 2012;54(4):321–35. Radiological review of SVD and small vessel anatomy in the brain. Proposal of a Novel diagnostic assessment strategy in WMH. Takes account lesion ethiopathogenesis.

Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32(6):1318–22.PubMed

10.

Xiong Y, Yang J, Wong A, Wong CHK, Chan SSW, Li HHS, et al. Operational definitions improve reliability of the age-related white matter changes scale. Eur J Neurol. 2011;18(5):744–9.PubMed

11.

Wijtenburg SA, McGuire SA, Rowland LM, Sherman PM, Lancaster JL, Tate DF, et al. Relationship between fractional anisotropy of cerebral white matter and metabolite concentrations measured using 1H magnetic resonance spectroscopy in healthy adults. Human Brain Mapping Journal. 2013;66:161–8.

12.

de Groot M, Verhaaren BFJ, de Boer R, Klein S, Hofman A, van der Lugt A, et al. Changes in normal-appearing white matter precede development of white matter lesions. Stroke. 2013;44(4):1037–42.PubMed

13.

Fazekas F, Schmidt R, Kleinert R, Kapeller P, Roob G, Flooh E. The spectrum of age-associated brain abnormalities: Their measurement and histopathological correlates. J Neural Transm Suppl. 1998;53:31–9.PubMed

14.

•• Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, et al. Heterogeneity of small vessel disease: A systematic review of MRI and histopathology correlations. Journal of Neurology, Neurosurgery & Psychiatry. 2011;82(2):126–35. Characterization of visible and “invisible” lesions seen on MRI by post-mortem histopathology and reviews more than 20 studies with pathological-Imaging correlations of SVD.

15.

Sirimarco G, Lavallée PC, Labreuche J, Meseguer E, Cabrejo L, Guidoux C, et al. Overlap of Diseases Underlying Ischemic Stroke: The ASCOD Phenotyping. Stroke 2013.

16.

Amarenco P, Bogousslavsky J, Caplan L, Donnan GA, Wolf ME, Hennerici MG. The ASCOD phenotyping of ischemic stroke (updated ASCO phenotyping). Cerebrovasc Dis. 2013;36(1):1–5.PubMed

17.

Schmidt H, Zeginigg M, Wiltgen M, Freudenberger P, Petrovic K, Cavalieri M, et al. Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease. Brain. 2011;134(Pt 11):3384–97.PubMed

18.

•• Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12(5):483–97. This is a thorough and updated review of clinical implications in SVD and insights from MRI studies.PubMed

19.

Maillard P, Carmichael O, Harvey D, Fletcher E, Reed B, Mungas D, et al. FLAIR and diffusion MRI signals are independent predictors of white matter hyperintensities. Am J Neuroradiol. 2013;34(1):54–61.PubMedCentralPubMed

20.

Seneviratne U, Chong W, Billimoria PH. Brain white matter hyperintensities in migraine: Clinical and radiological correlates. Clin Neurol Neurosurg. 2012;7:1–4.

21.

•• Aradi M, Schwarcz A, Perlaki G, Orsi G, Kovács N, Trauninger A, et al. Quantitative MRI studies of chronic brain white matter Hyperintensities in migraine patients. Headache. 2013;53(5):752–63. Migraine is one of the most prevalent neurologic conditions worldwide. This study examines evidence of white matter tissue damage secondary to migraine as correlated with white matter lesions frequently found on neuroimaging of migraine patients.PubMed

22.

Palm-Meinders IH, Koppen H, Terwindt GM, Launer LJ, Konishi J, Moonen JME, et al. Structural brain changes in migraine. JAMA. 2012;308(18):1889–97.PubMedCentralPubMed

23.

Tana C, Tafuri E, Tana M, Martelletti P, Negro A, Affaitati G, et al. New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: Is gold all that glitters? J Headache Pain. 2013;14(1):9.PubMedCentralPubMed

24.

Yu D, Yuan K, Zhao L, Dong M, Liu P, Yang X, et al. White matter integrity affected by depressive symptoms in migraine without aura: A tract-based spatial statistics study. NMR Biomed 2013.

25.

Rist PM, Kurth T. Migraine and cognitive decline: A topical review. Headache. 2013;53(4):589–98.PubMed

26.

Kochunov P, Glahn DC, Lancaster J, Winkler A, Karlsgodt K, Olvera RL, et al. Blood pressure and cerebral white matter share common genetic factors in Mexican Americans. Hypertension. 2011;57(2):330–5.PubMedCentralPubMed

27.

Gotoh K, Okada T, Satogami N, Yakami M, Takahashi JC, Yoshida K, et al. Evaluation of CT angiography for visualisation of the lenticulostriate artery: Difference between normotensive and hypertensive patients. Br J Radiol. 2012;85(1019):e1004–8.PubMed

28.

Aboyans V, Lacroix P, Criqui MH. Large and small vessels atherosclerosis: Similarities and differences. Prog Cardiovasc Dis. 2007;50(2):112–25.PubMed

29.

Brickman AM, Zahra A, Muraskin J, Steffener J, Holland CM, Habeck C, et al. Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res. 2009;172(2):117–20. Elsevier Ireland Ltd.PubMedCentralPubMed

30.

Pico F, Labreuche J, Seilhean D, Duyckaerts C, Hauw J-J, Amarenco P. Association of small-vessel disease with dilatative arteriopathy of the brain: Neuropathologic evidence. Stroke. 2007;38(4):1197–202.PubMed

31.

•• ten VH D, van den Heuvel DMJ, de Craen AJM, Bollen ELEM, Murray HM, Westendorp RGJ, et al. Decline in total cerebral blood flow is linked with increase in periventricular but not deep white matter hyperintensities. Radiology. 2007;243(1):198–203. Study showing different characteristics of Cerebral Blood Flow values in SVD through logistic regression by their two main locations (Periventricular and Deep White Matter).

32.

• Rabkin SW. Arterial stiffness: Detection and consequences in cognitive impairment and dementia of the elderly. J Alzheimers Dis. 2012;32(3):541–9. Summary of 12 studies looking at arterial stiffness in the pathogenesis of dementia in the elderly through non-invasive Pulse Wave Velocity.PubMed

33.

Brisset M, Boutouyrie P, Pico F, Zhu Y, Zureik M, Schilling S, et al. Large-vessel correlates of cerebral small-vessel disease. Neurology. 2013;80(7):662–9.PubMed

34.

Hatanaka R, Obara T, Watabe D, Ishikawa T, Kondo T, Ishikura K, et al. Association of arterial stiffness with silent cerebrovascular lesions: The ohasama study. Cerebrovasc Dis. 2011;31(4):329–37.PubMed

35.

• Makedonov I, Black SE, MacIntosh BJ. Cerebral small vessel disease in aging and Alzheimer’s disease: A comparative study using MRI and SPECT. Eur J Neurol. 2013;20(2):243–50. Comparison of SVD in aging and Alzheimer’s disease.PubMed

36.

• Giwa MO, Williams J, Elderfield K, Jiwa NS, Bridges LR, Kalaria RN, et al. Neuropathologic evidence of endothelial changes in cerebral small vessel disease. Neurology. 2012;78(3):167–74. Micropathology study of the blood vessel and associated endothelial changes in the pathophysiology of SVD.PubMed

37.

• Rouhl RPW, Mertens AECS, van Oostenbrugge RJ, Damoiseaux JGMC, Debrus-Palmans LL, Henskens LHG, et al. Angiogenic T-cells and putative endothelial progenitor cells in hypertension-related cerebral small vessel disease. Stroke. 2012;43(1):256–8. Inflammatory cells and possible mechanisms of the endothelium to prevent further damage are discussed view of the pathogenesis of SVD.PubMed

38.

Yang Y, Rosenberg GA. Blood–brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011;42(11):3323–8.PubMedCentralPubMed

39.

Wardlaw JM. Blood–brain barrier and cerebral small vessel disease. J Neurol Sci. 2010;299(1–2):66–71.PubMed

40.

Chen B, Friedman B, Whitney MA, Winkle JAV, Lei I-F, Olson ES, et al. Thrombin activity associated with neuronal damage during acute focal ischemia. J Neurosci. 2012;32(22):7622–31.PubMedCentralPubMed

41.

Bueche CZ, Garz C, Kropf S, Bittner D, Li W, Goertler M, et al. NAC changes the course of cerebral small vessel disease in SHRSP and reveals new insights for the meaning of stases - a randomized controlled study. Exp Transl Stroke Med. 2013;5(1):5.PubMedCentralPubMed

42.

Potter GM, Doubal FN, Jackson CA, Sudlow CLM, Dennis MS, Wardlaw JM. Lack of association of white matter lesions with ipsilateral carotid artery stenosis. Cerebrovasc Dis. 2012;33(4):378–84.PubMed

43.

•• Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701. Reviews the consequences of SVD on the brain in detail. Illustrates pathogenesis and symptom staging associated with SVD.PubMed

44.

Schmidt R, Schmidt H, Haybaeck J, Loitfelder M, Weis S, Cavalieri M, et al. Heterogeneity in age-related white matter changes. Acta Neuropathol. 2011;122(2):171–85.PubMed

45.

•• Schmidt R, Grazer A, Enzinger C, Ropele S, Homayoon N, Pluta-Fuerst A, et al. MRI-detected white matter lesions: Do they really matter? J Neural Transm. 2011;118(5):673–81. Reviews of known correlations between WMH and cognitive function. Draws predictive values for stroke, dementia and functional decline in ADL’s based on WMH burden.PubMed

46.

Seiler S, Cavalieri M, Schmidt R. Vascular cognitive impairment — An ill-defined concept with the need to define its vascular component. J Neurol Sci. 2012;322(1–2):11–6.PubMed

47.

van Norden AG, de Laat KF, Gons RA, van Uden IW, van Dijk EJ, van Oudheusden LJ, et al. Causes and consequences of cerebral small vessel disease. The RUN DMC study: A prospective cohort study. Study rationale and protocol. BMC Neurol. 2011;11(1):29. BioMed Central Ltd.PubMedCentralPubMed

48.

Duering M, Csanadi E, Gesierich B, Jouvent E, Hervé D, Seiler S, et al. Incident lacunes preferentially localize to the edge of white matter hyperintensities: Insights into the pathophysiology of cerebral small vessel disease. Brain. 2013.

49.

Jokinen H, Gouw AA, Madureira S, Ylikoski R, van Straaten ECW, van der Flier WM, et al. Incident lacunes influence cognitive decline: The LADIS study. Neurology. 2011;76(22):1872–8.PubMed

50.

Takeuchi H, Taki Y, Nouchi R, Hashizume H, Sekiguchi A, Kotozaki Y, et al. Effects of working memory training on functional connectivity and cerebral blood flow during rest. Cortex. 2012.

51.

Duering M, Gonik M, Malik R, Zieren N, Reyes S, Jouvent E, et al. Identification of a strategic brain network underlying processing speed deficits in vascular cognitive impairment. Neuroimage. 2013;66:177–83.

52.

Welker KM, De Jesus RO, Watson RE, Machulda MM, Jack Jr CR. Altered functional MR imaging language activation in elderly individuals with cerebral leukoaraiosis. Radiology. 2012;265(1):222–32. Radiological Society of North America.PubMed

53.

• Manenti R, Brambilla M, Petesi M, Miniussi C, Cotelli M. Compensatory networks to counteract the effects of ageing on language. Behav Brain Res. 2013;249:22–7. Explores active adaptations that the brain undergoes after normal and abnormal changes in aging through neuroplasticity and other strategies.PubMed

54.

• Jia Z, Mohammed W, Qiu Y, Hong X, Shi H. Hypertension Increases the Risk of Cerebral Microbleed in the Territory of Posterior Cerebral Artery: A Study of the Association of Microbleeds Categorized on a Basis of Vascular Territories and Cardiovascular Risk Factors. Journal of Stroke and Cerebrovascular Diseases. 2013. Association of hypertension with posterior cerebral artery territory cerebral microbleeds, a different mechanism from lobar microhemorrhages associated with amyloid angiopathy.

55.

Liu W, Liu R, Sun W, Peng Q, Zhang W, Xu E, et al. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions. Stroke. 2012;43(11):2916–22.PubMed

56.

Goos JDC, van der Flier WM, Knol DL, Pouwels PJW, Scheltens P, Barkhof F, et al. Clinical relevance of improved microbleed detection by susceptibility-weighted magnetic resonance imaging. Stroke. 2011;42(7):1894–900.PubMed

57.

van Norden AGW, van Uden IWM, de Laat KF, Gons RAR, Roy P.C. Kessels, van Dijk EJ, et al. Cerebral microbleeds are related to subjective cognitive failures: The RUN DMC study. NBA. 2013 1–6. Elsevier Ltd

58.

•• Otani H, Kikuya M, Hara A, Terata S, Ohkubo T, Kondo T, et al. Association of kidney dysfunction with silent lacunar infarcts and white matter hyperintensity in the general population: The ohasama study. Cerebrovasc Dis. 2010;30(1):43–50. This is a cross-sectional study done in Japan with 1008 patients called The Ohasama Study, which showed Creatinine Clearance as an independent risk factor in the elderly, especially when values fall under 60ml/min/1.73sqm, even in the presence or absence of hypertension.PubMed

59.

Devan WJ, Falcone GJ, Anderson CD, Jagiella JM, Schmidt H, Hansen BM, et al. Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage. Stroke. 2013;44(6):1578–83.PubMed

60.

•• Westover MB, Bianchi MT, Yang C, Schneider JA, Greenberg SM. Estimating cerebral microinfarct burden from autopsy samples. Neurology. 2013;80(15):1365–9. Pathological exploration of SVD and imaging-negative micropathologies. Routine sampling of the brain, as few as 1 or 2 microinfarcts may indicate the presence of thousands of lesions in the entire brain. Estimation of total microinfarcts was found to exceed the total burden when compared to the number of grossly visible lacunar infarcts and larger infarcts in the brain.PubMed

61.

Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al. Cerebral microbleeds: A guide to detection and interpretation. The Lancet Neurology. 2009;8(2):165–74.

62.

De Reuck JL. The significance of small cerebral bleeds in neurodegenerative dementia syndromes. Aging Dis. 2012;3(4):307–12.PubMedCentralPubMed

63.

Patel B, Lawrence AJ, Chung AW, Rich P, Mackinnon AD, Morris RG, et al. Cerebral microbleeds and cognition in patients with symptomatic small vessel disease. Stroke. 2013;44(2):356–61.PubMed

64.

• Charidimou A, Kakar P, Fox Z, Werring DJ. Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry. 2013;84(3):277–80. Meta-analysis of 790 patients over 5 studies and a review of the presence of Cerebral Microbleeds in the risk of intracerebral hemorrhage after thrombolytic administration for acute ischemic stroke. The available evidence does not demonstrate a statistically significant increased risk of symptomatic ICH although some considerations are advised.

65.

McCarron MO, Nicoll JAR. Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage. The Lancet Neurology. 2004;3(8):484–92.

66.

Caprio FZ, Maas MB, Rosenberg NF, Kosteva AR, Bernstein RA, Alberts MJJ, et al. Leukoaraiosis on magnetic resonance imaging correlates with worse outcomes after spontaneous intracerebral hemorrhage. Stroke. 2013;44(3):642–6.PubMed

67.

Yamamoto Y, Craggs L, Baumann M, Kalimo H, Kalaria RN. Review: Molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol. 2011;37(1):94–113.PubMed

68.

Kochunov P, Glahn DC, Lancaster JL, Winkler AM, Smith S, Thompson PM, et al. Genetics of microstructure of cerebral white matter using diffusion tensor imaging. Neuroimage. 2010;53(3):1109–16.PubMedCentralPubMed

69.

Szolnoki Z, Szaniszlo I, Szekeres M, Hitri K, Kondacs A, Mandi Y, et al. Evaluation of the MTHFR A1298C variant in leukoaraiosis. J Mol Neurosci. 2012;46(3):492–6.PubMed

70.

Nierenberg J, Pomara N, Hoptman MJ, Sidtis JJ, Ardekani BA, Lim KO. Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers. NeuroReport. 2005;16(12):1369–72.PubMed

71.

Anderson CD, Biffi A, Nalls MA, Devan WJ, Schwab K, Ayres AM, et al. Common variants within oxidative phosphorylation genes influence risk of ischemic stroke and intracerebral hemorrhage. Stroke Am Heart Assoc. 2013;44(3):612–9.

72.

Freudenberger P, Schmidt R, Schmidt H. Genetics of age-related white matter lesions from linkage to genome wide association studies. J Neurol Sci. 2012;322(1–2):82–6.PubMedCentralPubMed

73.

• Kanchibhotla SC, Mather KA, Wen W, Schofield PR, Kwok JBJ, Sachdev PS. Genetics of ageing-related changes in brain white matter integrity - a review. Ageing Res Rev. 2013;12(1):391–401. This paper reviews the studies probing for genetic associations of SVD. Mentions the results from a Genome-Wide Study and other candidate genes and the evidence towards their function in white matter disease. Genes in chromosome 3 and 15 and apoE are linked to Small Vessel Disease pathology so far.PubMed

74.

Paternoster L, Chen W, Sudlow CLM. Genetic determinants of white matter hyperintensities on brain scans: A systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19 000 subjects * supplemental references. Stroke. 2009;40(6):2020–6.PubMed

75.

Raz N, Yang Y, Dahle CL, Land S. Volume of white matter hyperintensities in healthy adults: Contribution of age, vascular risk factors, and inflammation-related genetic variants. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2012;1822(3):361–9.

76.

De Guio F, Reyes S, Duering M, Pirpamer L, Chabriat H, Jouvent E. Decreased T1 Contrast between Gray Matter and Normal-Appearing White Matter in CADASIL. Am J Neurorad. 2013.

77.

Ciolli L, Pescini F, Salvadori E, Del Bene A, Pracucci G, Poggesi A, et al. Influence of vascular risk factors and neuropsychological profile on functional performances in CADASIL: Results from the MIcrovascular LEukoencephalopathy Study (MILES). Eur J Neurol. 2013.

78.

Monet-Lepretre M, Haddad I, Baron-Menguy C, Fouillot-Panchal M, Riani M, Domenga-Denier V, et al. Abnormal recruitment of extracellular matrix proteins by excess Notch3ECD: A new pathomechanism in CADASIL. Brain. 2013.

79.

Cherubini A, Lowenthal DT, Paran E, Mecocci P, Williams LS, Senin U. Hypertension and cognitive function in the elderly. Dis Mon. 2010;56(3):106–47.PubMed

80.

Miller DH, Weinshenker BG, Filippi M, Banwell B, Cohen JA, Freedman M, et al. Differential diagnosis of suspected multiple sclerosis: A consensus approach. Mult Scler. 2008;14(9):1157–74.PubMedCentralPubMed

81.

Meschia JF. New information on the genetics of stroke. Current Neurology and neuroscience reports. 2010;11(1):35–41.

82.

Meschia JF, Worrall BB, Rich SS. Genetic susceptibility to ischemic stroke. Nat Rev Neurosci. 2011;7(7):369–78. Nature Publishing Group.

83.

Tillema J-M, Renaud D. Leukoencephalopathies in Adulthood. Semin Neurol. 2012;32(01):085–94.

84.

Yoneda Y, Haginoya K, Kato M, Osaka H, Yokochi K, Arai H, et al. Phenotypic spectrum of COL4A1Mutations: Porencephaly to schizencephaly. Ann Neurol. 2012;73(1):48–57.PubMed

85.

Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science. 2002;297(5580):353–6.PubMed

86.

Behrouz R, Malek AR, Torbey MT. Small vessel cerebrovascular disease: The past, present, and future. Stroke Research and Treatment. 2012;2012(1):1–8. 4 ed.

87.

Brickman AM, Provenzano FA, Muraskin J, Manly JJ, Blum S, Apa Z, et al. Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol. 2012;69(12):1621–7.PubMedCentralPubMed

88.

Leung KK, Bartlett JW, Barnes J, Manning EN, Ourselin S, Fox NC, et al. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: Rates and acceleration. Neurology. 2013.

89.

Jack Jr CR, Petersen RC, Xu YC, Waring SC, O'Brien PC, Tangalos EG, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 1997;49(3):786–94.PubMedCentralPubMed

90.

Dhikav V, Anand K. Potential predictors of hippocampal atrophy in Alzheimer’s disease. Drugs Aging. 2011;28(1):1–11. Springer.PubMed

91.

Henneman WJP, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC, et al. Hippocampal atrophy rates in Alzheimer disease: Added value over whole brain volume measures. Neurology. 2009;72(11):999–1007.PubMed

92.

Wiseman RM, Saxby BK, Burton EJ, Barber R, Ford GA, O'Brien JT. Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects. Neurology. 2004;63(10):1892–7.PubMed

93.

Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol. 1999;56(3):303–8.PubMed

94.

Okroglic S, Widmann CN, Urbach H, Scheltens P, Heneka MT. Clinical symptoms and risk factors in cerebral microangiopathy patients. Minnerup J. PLoS ONE. 2013;8(2):e53455.PubMedCentralPubMed

95.

Sakakibara R, Panicker J, Fowler CJ, Tateno F, Kishi M, Tsuyuzaki Y, et al. Vascular incontinence: Incontinence in the elderly due to ischemic white matter changes. Neurol Int. 2012;14:4(2).

96.

Kling MA, Trojanowski JQ, Wolk DA, Lee VMY, Arnold SE. Vascular disease and dementias: Paradigm shifts to drive research in new directions. Alzheimers Dement. 2013;9(1):76–92. Elsevier Ltd.PubMedCentralPubMed

97.

Price CC, Mitchell SM, Brumback B, Tanner JJ, Schmalfuss I, Lamar M, et al. MRI-leukoaraiosis thresholds and the phenotypic expression of dementia. Neurology. 2012;79(8):734–40.PubMed

98.

Kloppenborg RP, Nederkoorn PJ, Grool AM, Vincken KL, Mali WPTM, Vermeulen M, et al. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study. Neurology. 2012;79(20):2029–36.PubMed

99.

Gustavo C. Román. Chapter 2: Clinical Forms of Vascular Dementia. In: Vascular Dementia. Paul RH, Cohen R, Ott BR, Salloway S, (eds.) Humana Press; 2005.

100.

Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology. 1993;43:250–60.PubMed

101.

Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75.e2. Elsevier Ltd.PubMed

102.

Barnes J, Carmichael OT, Leung KK, Schwarz C, Ridgway GR, Bartlett JW, et al. Vascular and Alzheimer“s disease markers independently predict brain atrophy rate in Alzheimer”s Disease Neuroimaging Initiative controls. NBA. 2013;20:1–7. Elsevier Ltd.

103.

Hedden T, Mormino EC, Amariglio RE, Younger AP, Schultz AP, Becker JA, et al. Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. J Neurosci. 2012;32(46):16233–42.PubMedCentralPubMed

104.

Staekenborg SS, Su T, van Straaten ECW, Lane R, Scheltens P, Barkhof F, et al. Behavioural and psychological symptoms in vascular dementia; Differences between small- and large-vessel disease. Journal of Neurology, Neurosurgery & Psychiatry. 2010;81(5):547–51.

105.

Kim HJ, Kang SJ, Kim C, Kim GH, Jeon S, Lee J-M, et al. The effects of small vessel disease and amyloid burden on neuropsychiatric symptoms: A study among patients with subcortical vascular cognitive impairments. Neurobiol Aging. 2013.

106.

Srikanth V, Thrift AG, Fryer JL, Saling MM, Dewey HM, Sturm JW, et al. The validity of brief screening cognitive instruments in the diagnosis of cognitive impairment and dementia after first-ever stroke. Int Psychogeriatr. 2006;18(2):295–305.PubMed

107.

Zhao J, Tang H, Sun J, Wang B, Chen S, Fu Y. Analysis of cognitive dysfunction with silent cerebral infarction: A prospective study in Chinese patients. Metab Brain Dis. 2012;27(1):17–22.PubMed

108.

Bangert AS, Balota DA. Keep up the pace: Declines in simple repetitive timing differentiate healthy aging from the earliest stages of Alzheimer’s disease. J Int Neuropsychol Soc. 2012;18(06):1052–63.PubMedCentralPubMed

109.

Reijmer YD, Leemans A, Caeyenberghs K, Heringa SM, Koek HL, Biessels GJ, et al. Disruption of cerebral networks and cognitive impairment in Alzheimer disease. Neurology. 2013;80(15):1370–7.PubMed

110.

Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol. 1999;56(1):98–102.PubMed

111.

Rosano C, Longstreth WT, Boudreau R, Taylor CA, Du Y, Kuller LH, et al. High blood pressure accelerates gait slowing in well-functioning older adults over 18-years of follow-up. J Am Geriatr Soc. 2011;59(3):390–7.PubMedCentralPubMed

112.

Blahak C, Baezner H, Pantoni L, Poggesi A, Chabriat H, Erkinjuntti T, et al. Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: Cross sectional results from the LADIS study. Journal of Neurology, Neurosurgery & Psychiatry. 2009;80(6):608–13. BMJ Publishing Group Ltd.

113.

de Laat KF, Tuladhar AM, van Norden AGW, Norris DG, Zwiers MP, de Leeuw FE. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain. 2010;134(1):73–83.PubMed

114.

Thanvi B, Lo N, Robinson T. Vascular parkinsonism—an important cause of parkinsonism in older people. Age Ageing. 2005;34(2):114–9.PubMed

115.

Maillet A, Pollak P, Debu B. Imaging gait disorders in parkinsonism: A review. Journal of Neurology, Neurosurgery & Psychiatry. 2012;83(10):986–93.

116.

Wang H-C, Hsu J-L, Leemans A. Diffusion tensor imaging of vascular parkinsonism: structural changes in cerebral white matter and the association with clinical severity. Arch Neurol. 2012;69(10):1340–8.PubMed

117.

Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99–143. Elsevier Ltd.PubMed

118.

Dalby RB, Frandsen J, Chakravarty MM, Ahdidan J, Sørensen L, Rosenberg R, et al. Correlations between Stroop task performance and white matter lesion measures in late-onset major depression. Psychiatry Res. 2012;202(2):142–9. Elsevier Ireland Ltd.PubMed

119.

Aizenstein HJ, Andreescu C, Edelman KL, Cochran JL, Price J, Butters MA, et al. fMRI correlates of white matter hyperintensities in late-life depression. Am J Psychiatry. 2011;168(10):1075–82.PubMedCentralPubMed

120.

Perez HCS, Direk N, Hofman A, Vernooij MW, Tiemeier H, Ikram MA. Silent brain infarcts A cause of depression in the elderly? Psychiatry Res. 2013;211(2):180–2. Elsevier.

121.

Thomas A. A neuropathological study of periventricular white matter hyperintensities in major depression. J Affect Disord. 2003;76(1–3):49–54.PubMed

122.

Pompili M, Innamorati M, Mann JJ, Oquendo MA, Lester D, Del Casale A, et al. Periventricular white matter hyperintensities as predictors of suicide attempts in bipolar disorders and unipolar depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32(6):1501–7.

123.

Ramadan HH, Vinjam M, Macmullen-Price J, Hassan A. Susac’s syndrome. Pract Neurol. 2012;12(4):263–5.PubMed

124.

Boesch SM, Plörer AL, Auer AJ, POEWE W, Aichner FT, Felber SR, et al. The natural course of sneddon syndrome: Clinical and magnetic resonance imaging findings in a prospective six year observation study. Journal of Neurology, Neurosurgery & Psychiatry. 2003;74(4):542–4.

125.

Khan U, Porteous L, Hassan A, Markus HS. Risk factor profile of cerebral small vessel disease and its subtypes. Journal of Neurology, Neurosurgery & Psychiatry. 2007;78(7):702–6.

126.

Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. The Lancet Neurology. 2005;4(8):487–99.

127.

Launer LJ, Hughes T, Yu B, Masaki K, Petrovitch H, Ross GW, et al. Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia perspective from the Honolulu heart program/Honolulu Asia aging study. Hypertension Am Heart Assoc. 2010;55(6):1352–9.

128.

Reis JP, Loria CM, Launer LJ, Sidney S, Liu K, Jacobs DR, et al. Cardiovascular health through young adulthood and cognitive functioning in midlife. Ann Neurol. 2013;73(2):170–9.PubMed

129.

Verhaaren BFJ, Vernooij MW, de Boer R, Hofman A, Niessen WJ, van der Lugt A, et al. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension. 2013;61(6):1354–9.PubMed

130.

Jones WS, Vemulapalli S, Patel MR. Interventional treatment of hypertension: A new paradigm. Curr Cardiol Rep. 2013;15(5):356.PubMed

131.

van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MMB. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam scan study. Stroke. 2008;39(10):2712–9.PubMed

132.

Schmidt R, Petrovic K, Ropele S, Enzinger C, Fazekas F. Progression of leukoaraiosis and cognition. Stroke. 2007;38(9):2619–25.PubMed

133.

Sachdev PS, Wen W, Chen X, Brodaty H. Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology. 2007;68(3):214–22.PubMed

134.

Bowler JV. The concept of vascular cognitive impairment. J Neurol Sci. 2002;203–204:11–5.PubMed

135.

Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives a prospective study. Circulation Am Heart Assoc; 2003;107(10):1401–6.

136.

Alosco ML, Spitznagel MB, Raz N, Cohen R, Sweet LH, Colbert LH, et al. Obesity interacts with cerebral hypoperfusion to exacerbate cognitive impairment in older adults with heart failure. Cerebrovasc Dis Extra. 2012;2(1):88–98.PubMedCentralPubMed

137.

• Jung H-W, Kim K-I. Blood pressure variability and cognitive function in the elderly. Pulse. 2013;1(1):29–34. This article discusses the considerations in maintaining normotension in the elderly to reduce the risk of cognitive impairment while maintaining the benefits of anti-hypertensive therapy in selected populations.

138.

Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients: Advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996;27(1):130–5.PubMed

139.

Sierra C. Associations between ambulatory blood pressure parameters and cerebral white matter lesions. Int J Hypertens. 2011; ID: 478710.

140.

Durgan DJ, Bryan RM. Cerebrovascular consequences of obstructive sleep apnea. Journal of the American Heart Association. Am Heart Assoc. 2012;1(4).

141.

•• Canessa N, Castronovo V, Cappa SF, Aloia MS, Marelli S, Falini A, et al. Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med. 2011;183(10):1419–26. This study shows the impact of Obstructive Sleep Apnea Syndrome (OSAS) in brain structure and function. Follows up data with reversible changes after treatment of OSAS.PubMed

142.

Zimmerman ME, Aloia MS. A review of neuroimaging in obstructive sleep apnea. J Clin Sleep Med. 2006;2(4):461–71.PubMed

143.

Vogels SCM, Emmelot-Vonk MH, Verhaar HJJ, Koek HDL. The association of chronic kidney disease with brain lesions on MRI or CT: A systematic review. Maturitas. 2012;71(4):331–6. Elsevier Ireland Ltd.PubMed

144.

Nickolas TL, Khatri M, Boden-Albala B, Kiryluk K, Luo X, Gervasi-Franklin P, et al. The association between kidney disease and cardiovascular risk in a multiethnic cohort: Findings from the northern Manhattan study (NOMAS). Stroke. 2008;39(10):2876–9.PubMedCentralPubMed

145.

Takahashi W, Tsukamoto Y, Takizawa S, Kawada S, Takagi S. Relationship between chronic kidney disease and white matter hyperintensities on magnetic resonance imaging. J Stroke Cerebrovasc Dis. 2012;21(1):18–23.PubMed

146.

Ikram MA, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Breteler MMB. Kidney function is related to cerebral small vessel disease. Stroke. 2007;39(1):55–61.PubMed

147.

Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Intern Med J. 2012;42(5):484–91.PubMed

148.

Imamine R, Kawamura T, Umemura T, Umegaki H, Kawano N, Hotta M, et al. Does cerebral small vessel disease predict future decline of cognitive function in elderly people with type 2 diabetes? Diabetes Res Clin Pract. 2011;94(1):91–9.PubMed

149.

Roriz-Filho SJ, Sá-Roriz TM, Rosset I, Camozzato AL, Santos AC, Chaves MLF, et al. (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2009;1792(5):432–43.

150.

Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev. 2008;29(4):494–511.PubMed

151.

Zhen YF, Zhang J, Liu XY, Fang H, Tian LB, Zhou DH, et al. Low BDNF is associated with cognitive deficits in patients with type 2 diabetes. Psychopharmacology. 2012;227(1):93–100.PubMed

152.

Matei D, Popescu CD, Ignat B, Matei R. Autonomic dysfunction in type 2 diabetes mellitus with and without vascular dementia. J Neurol Sci. 2013;325(1–2):6–9.PubMed

153.

Williamson JB, Lewis GF, Nyenhuis DL, Stebbins GT, Murphy C, Handelman M, et al. The effects of cerebral white matter changes on cardiovascular responses to cognitive and physical activity in a stroke population. Psychophysiology. 2012;49(12):1618–28.PubMed

154.

• Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO, Erkinjuntti T, et al. White matter changes and diabetes predict cognitive decline in the elderly The LADIS Study. American Academy of Neurology AAN Enterprises. 2010;75(2):160–7. Results from the LADIS study on predictin cognitive decline in diabetic patients through neuroimaging.

155.

Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ. An update on type 2 diabetes, vascular dementia and Alzheimer’s disease. Exp Gerontol. 2012;47(11):858–64.PubMed

156.

• Feng L, Isaac V, Sim S, Ng T-P, Krishnan KRR, Chee MWL. Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults. Am J Geriatr Psychiatry. 2013;21(2):164–72. High blood homocysteine levels are associated with higher SVD morbidity, although treating hyperhomocysteinemia has not shown a reduction or improvement of lesions in brain neuroimaging.PubMed

157.

Feng C, Bai X, Xu Y, Hua T, Huang J, Liu X-Y. Hyperhomocysteinemia associates with small vessel disease more closely than large vessel disease. Int J Med Sci. 2013;10(4):408–12.PubMedCentralPubMed

158.

Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain. 2004;127(Pt 1):212–9.PubMed

159.

Fein G, Shimotsu R, Di Sclafani V, Barakos J, Harper C. Increased white matter signal hyperintensities in long-term abstinent alcoholics compared with nonalcoholic controls. Alcohol Clin Exp Res. 2009;33(1):70–8.PubMedCentralPubMed

160.

• Gazdzinski S, Durazzo TC, Mon A, Yeh P-H, Meyerhoff DJ. Cerebral white matter recovery in abstinent alcoholics—a multimodality magnetic resonance study. Brain. 2010;133(4):1043–53. White matter partial recovery after abstinence was seen in a population of alcoholics through MRI modalities, opening the discussion to white matter lesion mechanisms and possibility of lesion regression or repair.PubMed

161.

Kim SH, Yun C-H, Lee S-Y, Choi K-H, Kim MB, Park H-K. Age-dependent association between cigarette smoking on white matter hyperintensities. Neurol Sci. 2011;33(1):45–51.PubMed

162.

Longstreth WT, Arnold AM, Beauchamp NJ, Manolio TA, Lefkowitz D, Jungreis C, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly. Stroke. 2005;36(1):56–61.PubMed

163.

Kim JH, Hwang KJ, Kim J-H, Lee YH, Rhee HY, Park K-C. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer’s disease. J Clin Neurosci. 2011;18(8):1101–6.PubMed

164.

Gardener H, Scarmeas N, Gu Y, Boden-Albala B, Elkind MSV, Sacco RL, et al. Mediterranean diet and white matter hyperintensity volume in the Northern Manhattan Study. Arch Neurol. 2012;69(2):251–6.PubMedCentralPubMed

165.

Obisesan TO, Gillum RF, Johnson S, Umar N, Williams D, Bond V, et al. Neuroprotection and neurodegeneration in Alzheimer’s disease: Role of cardiovascular disease risk factors, implications for dementia rates, and prevention with aerobic exercise in African Americans. Int J Alzheimers Dis. 2012;2012(16):1–14.

166.

Kim YS, Park SS, Lee SH, Yoon BW. Reduced severity of strokes in patients with silent brain infarctions. Eur J Neurol. 2010;18(7):962–71.PubMed

167.

Ovbiagele B, Saver JL. Cerebral white matter hyperintensities on MRI: Current concepts and therapeutic implications. Cerebrovasc Dis. 2006;22(2–3):83–90.PubMed

168.

Candelario-Jalil E, Thompson J, Taheri S, Grossetete M, Adair JC, Edmonds E, et al. Matrix metalloproteinases are associated with increased blood–brain barrier opening in vascular cognitive impairment. Stroke. 2011;42(5):1345–50.PubMedCentralPubMed

169.

Smith EE, Schneider JA, Wardlaw JM, Greenberg SM. Cerebral microinfarcts: The invisible lesions. Lancet Neurol. 2012;11(3):272–82.PubMedCentralPubMed

170.

•• Terry T, Raravikar K, Chokrungvaranon N, Reaven PD. Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. Curr Cardiol Rep. 2012;14(1):79–88. Results from various clinical trials looking at aggressive glycemic control in reducing the risk of microvascular disease such as SVD.PubMed

171.

Li G, Rhew IC, Shofer JB, Kukull WA, Breitner JCS, Peskind E, et al. Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study. J Am Geriatr Soc. 2007;55(8):1161–7.PubMed

172.

Slavin MJ, Brodaty H, Sachdev PS. Challenges of Diagnosing Dementia in the Oldest Old Population. J. Gerontol. A Biol Sci Med Sci. 2013.

173.

Kravitz E, Schmeidler J, Schnaider BM. Cognitive decline and dementia in the oldest-old. RMMJ. 2012;3(4):e0026.PubMed

174.

Nelson M, Reid C, Beilin L, Donnan G, Johnston C, Krum H, et al. Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in reducing events in the elderly (ASPREE). Drugs Aging. 2003;20(12):897–903.PubMed

175.

• Maillard P, Seshadri S, Beiser A, Himali JJ, Au R, Fletcher E, et al. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham heart study: A cross-sectional study. The Lancet Neurology. 2012;11:1039–47. Results from the Framingham Heart Cross-Sectional Study in young adults to assess the effects of mid-life hypertension in the risk of Small Vessel Disease of the brain.

176.

Blumenthal JA, Smith PJ, Welsh-Bohmer K, Babyak MA, Browndyke J, Lin P-H, et al. Can lifestyle modification improve neurocognition? Rationale and design of the ENLIGHTEN clinical trial. Contemp Clin Trials. 2013;34(1):60–9.PubMedCentralPubMed

177.

Valenzuela MJ, Matthews FE, Brayne C, Ince P, Halliday G, Kril JJ, et al. Multiple biological pathways link cognitive lifestyle to protection from dementia. BPS. 2012;71(9):783–91.

178.

Baskys A, Cheng J-X. Pharmacological prevention and treatment of vascular dementia: Approaches and perspectives. EXG. 2012;47(11):887–91.

179.

Skoog I, Korczyn AD, Guekht A. Neuroprotection in vascular dementia: A future path. J Neurol Sci. 2012;322(1–2):232–6.PubMed

180.

Nithianantharajah J, Hannan AJ. Mechanisms mediating brain and cognitive reserve: Experience-dependent neuroprotection and functional compensation in animal models of neurodegenerative diseases. Progress in Neuropsychopharmacology & Biological Psychiatry. 2011;35(2):331–9.

181.

Schmidt W, Endres M, Dimeo F, Jungehulsing GJ. Train the vessel, gain the brain: physical activity and vessel function and the impact on stroke prevention and outcome in cerebrovascular disease. Cerebrovasc Dis. 2013;35(4):303–12.PubMed

182.

Ahlskog JE, Geda YE, Graff-Radford NR, Petersen RC. Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc. 2011;86(9):876–84.PubMed

183.

Eyre H, Baune BT. Neuroimmunological effects of physical exercise in depression. Brain Behav Immun. 2012;26(2):251–66.PubMed

184.

Bridle C, Spanjers K, Patel S, Atherton NM, Lamb SE. Effect of exercise on depression severity in older people: Systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry. 2012;201(3):180–5.PubMed

185.

Karcher H-S, Holzwarth R, Mueller H-P, Ludolph AC, Huber R, Kassubek J, et al. Body fat distribution as a risk factor for cerebrovascular disease: An MRI-based body fat quantification study. Cerebrovasc Dis. 2013;35(4):341–8.PubMed

186.

Siervo M, Arnold R, Wells JCK, Tagliabue A, Colantuoni A, Albanese E, et al. Intentional weight loss in overweight and obese individuals and cognitive function: A systematic review and meta-analysis. Obes Rev. 2011;12(11):968–83.PubMed

187.

Unverzagt FW, Guey LT, Jones RN, Marsiske M, King JW, Wadley VG, et al. ACTIVE cognitive training and rates of incident dementia. J Int Neuropsychol Soc. 2012;18(04):669–77.PubMedCentralPubMed

188.

Williams KN, Kemper S. Interventions to reduce cognitive decline in aging. J Psychosoc Nurs Ment Health Serv. 2010;48(5):42–51.PubMedCentralPubMed

189.

Steinerman JR. Minding the aging brain: Technology-enabled cognitive training for healthy elders. Current Neurology and neuroscience reports. 2010;10(5):374–80.PubMed

190.

Schneider N, Yvon C. A Review of multidomain interventions to support healthy cognitive ageing. J Nutri, Health Aging. 2009;1–6.

191.

Roman GC, Salloway S, Black SE, Royall DR, DeCarli CS, Weiner MW, et al. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia differential effects by Hippocampal size. Stroke Am Heart Assoc. 2010;41(6):1213–21.

192.

• Gorelick PB, Scuteri A, Black SE, DeCarli CS, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2011;42(9):2672–713. AHA/ASA 2011 statement on vascular contributions on cognitive impairment and Alzheimer’s and Vascular dementia.PubMedCentralPubMed

193.

Jahanshad N, Kochunov P, Sprooten E, Mandl RC, Nichols TE, Almassy L, et al. Multi-site genetic analysis of diffusion images and voxelwise heritability analysis: A pilot project of the ENIGMA–DTI working group. Hum Brain Mapp J. 2013;1:1–15.

Titel: Small Vessel Disease and Memory Loss: What the Clinician Needs to Know to Preserve Patients’ Brain Health
verfasst von: Christian Schenk
Timothy Wuerz
Alan J. Lerner
Publikationsdatum: 01.12.2013
Verlag: Springer US
Erschienen in: Current Cardiology Reports / Ausgabe 12/2013
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-013-0427-6

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2013

The Challenge of Stroke Prevention with Intracranial Arterial Stenosis

Sudden Unexpected Death in Epilepsy or Voodoo Heart: Analysis of Heart/Brain Connections

Cerebral Microbleeds and Macrobleeds: Should They Influence Our Recommendations for Antithrombotic Therapies?

Acute Hypertensive Response Management in Patients with Acute Stroke